raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:615964

Acute reversible leukoencephalopathy with increased urinary alpha-ketoglutarate

Synonyms: Acute reversible leukoencephalopathy due to SLC13A3 deficiency · Acute reversible leukoencephalopathy due to sodium-dependent dicarboxylate transporter deficiency

Type
Disease
Group
Disorder
Age of onset
Adult, Childhood
Status
active

A rare neurometabolic disease characterized by acute, reversible, and sometimes recurrent neurologic deterioration (including drowsiness, hypotonia, dysarthria, and ataxia) during a febrile illness. The condition is associated with reversible leukoencephalopathy and persistently increased urinary excretion (and sometimes cerebrospinal fluid concentration) mainly of alpha-ketoglutarate and N-acetylaspartate.

1

Names in Orphadata languages

10 of 12 languages
LangNameSynonyms
enAcute reversible leukoencephalopathy with increased urinary alpha-ketoglutarateAcute reversible leukoencephalopathy due to SLC13A3 deficiency · Acute reversible leukoencephalopathy due to sodium-dependent dicarboxylate transporter deficiency
frLeucoencéphalopathie réversible aiguë avec augmentation de l'alpha-cétoglutarate urinaireLeucoencéphalopathie aiguë réversible par déficit en SLC13A3
deAkute reversible Leukoenzephalopathie mit erhöhtem Alpha-Ketoglutarat im UrinAkute reversible Leukoenzephalopathie durch natriumabhängigen Dicarboxylat-Transporter-Mangel · Akute reversible Leukoenzephalopathie durch SLC13A3-Defizienz
esLeucoencefalopatía aguda reversible con aumento de alfa-cetoglutarato en orinaLeucoencefalopatía aguda reversible por deficiencia de SLC13A3 · Leucoencefalopatía aguda reversible por deficiencia del transportador de dicarboxilato dependiente de sodio
itLeucoencefalopatia acuta reversibile con aumento di alfa-chetoglutarato nelle urineLeucoencefalopatia acuta reversibile da deficit del trasportatore del dicarbossilato sodio-dipendente · Leucoencefalopatia acuta reversibile da deficit di SLC13A3
nlAcute reversibele leuko-encefalopathie met verhoogd alfa-ketoglutaraat in urineAcute reversibele leuko-encefalopathie door SLC13A3-deficiëntie · Acute reversibele leuko-encefalopathie door deficiëntie van natriumafhankelijke dicarboxylaattransporter
ptLeucoencefalopatia aguda reversível com aumento de alfa-cetoglutarato urinárioLeucoencefalopatia aguda reversível devido a deficiência SLC13A3 · Leucoencefalopatia aguda reversível devido a deficiência do transportador dicarboxilato sódio-dependente
plOstra odwracalna leukoencefalopatia ze zwiększonym wydalaniem alfa-ketoglutaranu w moczu= en
csAkutní reverzibilní leukoencefalopatie se zvýšenou hladinou alfa-ketoglutarátu v moči= en
ukГостра оборотна лейкоенцефалопатія з підвищенням рівня альфа-кетоглутарату в сечіГостра оборотна лейкоенцефалопатія, спричинена дефіцитом SLC13A3 · Гостра оборотна лейкоенцефалопатія внаслідок дефіциту натрійзалежного дикарбоксилатного транспортера

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM618384Evalidated
ICD-10E75.2NTBTattributedvalidated
ICD-115C53.1NTBTattributedvalidated
MONDO0032716Evalidated
UMLSC5193068Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families7 casesWorldwideCase(s)Validated38235040[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidated38235040[PMID]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card